Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone

Pharmacological Research

Volumn 111, Issue , 2016, Pages 859-866

  Kiscsatári, Laura ^a   Varga, Zoltán ^a   Schally, Andrew V ^b   Gáspár, Renáta ^c,d   Nagy, Csilla Terézia ^e   Giricz, Zoltán ^e   Ferdinandy, Péter ^d,e   Fábián, Gabriella ^a   Kahán, Zsuzsanna ^a   Görbe, Anikó ^c,d,e  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

^d PHARMAHUNGARY GROUP   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiac myocytes; Cardioprotection; GHRH agonists; GHRH SV1 receptors; Radiation damage

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; ISOPROTEIN; JI 34; MITOGEN ACTIVATED PROTEIN KINASE; MR 356; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN VARIANT; RADIOPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GH-RH(1-29), DESAMINOTYROSYL(1)-ORNITHYL(12,21)-ALPHA-AMINOBUTRYIC ACID(15)-NORLEUCYL(27)-ASPARTYL(28)-AGMATINE(29)-; HORMONE RECEPTOR; NEUROPEPTIDE RECEPTOR; PEPTIDE FRAGMENT; PROSTAGLANDIN E1; SOMATOCRININ RECEPTOR; SOMATOTROPIN RELEASING HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL DAMAGE; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVATION; HEART CELL CULTURE; HEART MUSCLE INJURY; HEART PROTECTION; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION INJURY; RAT; WESTERN BLOTTING; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CARDIOTOXICITY; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; RADIATION RESPONSE; SIGNAL TRANSDUCTION; WISTAR RAT;

ALPROSTADIL; ANIMALS; ANIMALS, NEWBORN; CARDIOTOXICITY; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE-RELEASING HORMONE; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; RADIATION-PROTECTIVE AGENTS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; SIGNAL TRANSDUCTION;

EID: 84982855904     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.07.036     Document Type: Article

References (31)

1. [1] Adams, M.J., Hardenbergh, P.H., Constine, L.S., Lipshultz, S.E., Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 45 (2003), 55–75.
2. [2] Andratschke, N., Maurer, J., Molls, M., Trott, K.R., Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother. Oncol. 100 (2011), 160–166.
3. [3] Aleman, B.M.P., Re, D., Diehl, V., The role of radiation therapy in patients with Hodgkin's lymphoma. Curr. Hematol. Malig. Rep. 2 (2007), 151–160.
4. [4] Stewart, F.A., Seemann, I., Hoving, S., Russell, N.S., Understanding radiation-induced cardiovascular damage and strategies for intervention. Clin. Oncol. (R. Coll. Radiol.) 25 (2013), 617–624.
5. [5] Schultz-Hector, S., Trott, K.R., Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007), 10–18.
6. [6] Stewart, F.A., Heeneman, S., Te Poele, J., Kruse, J., Russell, N.S., Gijbels, M., Daemen, M., Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE−/−mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am. J. Pathol. 168 (2006), 649–658.
7. [7] Darby, S., McGale, P., Taylor, C.W., Peto, R., Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6 (2005), 557–565.
8. [8] Darby, S.C., Ewertz, M., McGale, P., Bennet, A.M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., Hall, P., Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368 (2013), 987–998.
9. [9] Gabriels, K., Hoving, S., Seemann, I., Visser, N.L., Gijbels, M.J., Pol, J.F., Daemen, M.J., Stewart, F.A., Heeneman, S., Local heart irradiation of ApoE(−/−) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother. Oncol. 105 (2012), 358–364.
10. [10] Schultz-Hector, S., Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int. J. Radiat. Biol. 61 (1992), 149–160.
11. [11] Cilliers, G.D., Harper, I.S., Lochner, A., Radiation induced changes in the ultrastructure and mechanical function of the rat heart. Radiother. Oncol. 16 (1989), 311–326.
12. [12] Ling, N., Esch, F., Böhlen, P., Brazeau, P., Wehrenberg, W.B., Guillemin, R., Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc. Natl. Acad. Sci. U. S. A. 81 (1984), 4302–4306.
13. [13] Kiaris, H., Chatzistamou, I., Papavassilliou, A.G., Schally, A.V., Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 22 (2011), 311–317.
14. [14] Martin, B., Lopez de Maturana, R., Brenneman, R., Walent, T., Mattson, M.P., Maudsley, S., Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromol. Med. 7 (2005), 3–36.
15. [15] Bellyei, S., Schally, A.V., Zarandi, M., Varga, J.L., Vidaurre, I., Pozsgai, E., GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro. Cancer Lett. 293 (2010), 31–40.
16. [16] Halmos, G., Schally, A.V., Czompoly, T., Krupa, M., Varga, J., Rekasi, Z., Expression of growth hormon relasing hormone and splice variants in human prostate cancer. J. Clin. Endocrinol. Metab. 87 (2002), 4707–4714.
17. [17] B. Kővári, O. Rusz, A.V. Schally, Z. Kahán, G. Cserni, Differential immunostaining of various types of breast carcinomas for growth hormone releasing hormone receptor—Apocrine epithelium and carcinomas emerging as uniformly positive APMIS, 122, 2014. 824–831.
18. [18] Barabutis, N., Siejka, A., Schally, A.V., Block, N.L., Cai, R., Varga, J.L., Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. J. Mol. Endocrinol. 44 (2010), 127–134.
19. [19] Granata, R., Trovato, L., Gallo, M.P., Destefanis, S., Settanni, F., Scarlatti, F., Brero, A., Ramella, R., Volante, M., Isgaard, J., Levi, R., Papotti, M., Alloatti, G., Ghigo, E., Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc. Res. 83 (2009), 303–312.
20. [20] Kanashiro-Takeuchi, R.M., Szalontay, L., Schally, A.V., Takeuchi, L.M., Popovics, P., Jaszberenyi, M., Vidaurre, I., Zarandi, M., Cai, R.Z., Block, N.L., Hare, J.M., Rick, F.G., New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget 6 (2015), 9728–9739.
21. [21] Penna, C., Settanni, F., Tullio, F., Trovato, L., Pagliaro, P., Alloatti, G., Ghigo, E., Granata, R., GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology 154 (2013), 1624–1635.
22. [22] Kanashiro-Takeuchi, R.M., Takeuchi, L.M., Rick, F.G., Dulce, R., Treuer, A.V., Florea, V., Rodrigues, C.O., Paulino, E.C., Hatzistergos, K.E., Selem, S.M., Gonzalez, D.R., Block, N.L., Schally, A.V., Hare, J.M., Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc. Natl. Acad. Sci. U. S. A. 109 (2011), 559–563.
23. [23] Cai, R., Schally, A.V., Cui, T., Szalontay, L., Halmos, G., Sha, W., Kovacs, M., Jaszberenyi, M., He, J., Rick, F.G., Popovics, P., Kanashiro-Takeuchi, R., Hare, J.M., Block, N.L., Zarandi, M., Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides 52 (2014), 104–112.
24. [24] Kanashiro-Takeuchi, R.M., Tziomalos, K., Takeuchi, L.M., Treuer, A.V., Lamirault, G., Dulce, R., Hurtado, M., Song, Y., Block, N.L., Rick, F., Kulkovits, A., Hu, Q., Varga, J.L., Schally, A.V., Hare, J.M., Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 2604–2609.
25. [25] Gorbe, A., Giricz, Z., Szunyog, A., Csont, T., Burley, D.S., Baxter, G.F., Ferdinandy, P., Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Res. Cardiol. 105 (2010), 643–650.
26. [26] Szűcs, G., Murlasits, Z., Török, S., Kocsis, G.F., Pálóczi, J., Görbe, A., Csont, T., Csonka, C., Ferdinandy, P., Cardioprotection by farnesol: role of the mevalonate pathway. Cardiovasc. Drugs Ther. 27 (2013), 269–277.
27. [27] Csonka, C., Kupai, K., Bencsik, P., Görbe, A., Pálóczi, J., Zvara, A., Puskas, L.G., Csont, T., Ferdinandy, P., Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive potassium channel activators cromakalim and diazoxide. Am. J. Physiol. Heart Circ. Physiol. 306 (2014), 405–413.
28. [28] Csont, T., Bereczki, E., Bencsik, P., Fodor, G., Görbe, A., Zvara, A., Csonka, C., Puskás, L.G., Sántha, M., Ferdinandy, P., Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc. Res. 76 (2007), 100–109.
29. [29] Drigotas, M., Affolter, A., Mann, W.J., Brieger, J., Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response. J. Oral Pathol. Med. 42 (2013), 612–619.
30. [30] Salata, C., Ferreira-Machado, S.C., De Andrade, C.B., Mencalha, A.L., Mandarim-De-Lacerda, C.A., de Almeida, C.E., Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy. Int. J. Radiat. Biol. 90 (2014), 284–290.
31. [31] Abdel-Wahab, M., Schally, A.V., Rick, G.F., Szalontay, L., Block, L.N., Jorda, M., Mahmoud, O., Markoe, A., Shi, Y.F., Reiner, T., Zarandi, M., Duncan, R., Antagonists of growth hormone releasing hormone (GHRH) given before whole body radiation lead to modulation of radiation response and organ-specific changes in the expression of angiogenesis. J. Radiat. Oncol. 1 (2012), 389–396.